sclc treatment: synergism between nmda receptor blockade and chemotherapy- video abstract id 183885
Published 5 years ago • 449 plays • Length 3:28Download video MP4
Download video MP3
Similar videos
-
4:07
combination chemotherapy with zyflamend – video abstract [id 162255]
-
3:01
evaluation of dacomitinib for metastatic nsclc - video abstract [id 194231]
-
2:52
immunotherapy treatments for small cell lung cancer (sclc)
-
3:30
immunotherapy treatments for non-small cell lung cancer (nsclc)
-
0:49
should radiation be added to chemotherapy for induction treatment in lung cancer?
-
0:58
combining immunotherapy and chemotherapy in patients with sclc
-
3:14
radiation for lung cancer
-
4:17
how does lung cancer affect the body?
-
1:20:51
nccn patient webinar: small cell lung cancer
-
1:53
dr. spigel on pembrolizumab/chemo combo in first-line nsclc
-
36:48
personalized therapy for nsclc: biomarker testing, treatment & management in met alterations
-
3:02
osimertinib for treating non-small cell lung cancer
-
0:29
immunotherapy moves to sclc, but chemotherapy is still a mainstay
-
2:28
lurbinectedin for second line treatment of small cell lung cancer
-
3:26
sugemalimab plus platinum-based chemotherapy for metastatic non-small-cell lung cancer
-
3:58
second line chemotherapy options for sclc
-
0:48
immunotherapy for patients with small-cell lung cancer
-
1:19
what are my options for treatment and management of small cell lung cancer (sclc)?
-
1:30
immunotherapy in second-line treatment of non-small cell lung cancer
-
1:23
limited-stage sclc management
-
1:14
dr. halmos on second-line treatment in metastatic squamous nsclc
-
1:40
maintenance therapies for patients with non-small cell lung cancer